JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Kodu・Aktsiate loetelu・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Suletud

SektorTervishoid

1.17 -7.87

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.17

Max

1.38

Põhinäitajad
By Trading Economics
Sissetulek	-16M -13M
Müük	-15M 14M
Kasumimarginaal	-90.037
Töötajad	103
EBITDA	-16M -10M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+214.84% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-40M 454M
Eelmine avamishind	9.04
Eelmine sulgemishind	1.17

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

0.6863 / 0.72 Toetus ja vastupanu

Lexicon Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. veebr 2026, 23:57 UTC

Tulu

Naver Has Record Year Despite Weaker Final Quarter

5. veebr 2026, 23:45 UTC

Kuumad aktsiad

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5. veebr 2026, 22:26 UTC

Tulu

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5. veebr 2026, 22:00 UTC

Tulu

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5. veebr 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

5. veebr 2026, 23:47 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5. veebr 2026, 23:43 UTC

Market Talk

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5. veebr 2026, 23:37 UTC

Market Talk

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5. veebr 2026, 23:20 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5. veebr 2026, 23:11 UTC

Market Talk

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5. veebr 2026, 23:09 UTC

Tulu

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5. veebr 2026, 23:08 UTC

Tulu

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5. veebr 2026, 23:07 UTC

Tulu

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5. veebr 2026, 23:03 UTC

Market Talk

Tulu

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5. veebr 2026, 23:03 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5. veebr 2026, 23:00 UTC

Tulu

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5. veebr 2026, 23:00 UTC

Tulu

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5. veebr 2026, 22:59 UTC

Tulu

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5. veebr 2026, 22:59 UTC

Tulu

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5. veebr 2026, 22:52 UTC

Tulu

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5. veebr 2026, 22:45 UTC

Tulu

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5. veebr 2026, 22:37 UTC

Market Talk

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5. veebr 2026, 22:11 UTC

Tulu

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5. veebr 2026, 22:03 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5. veebr 2026, 22:01 UTC

Tulu

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5. veebr 2026, 21:59 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5. veebr 2026, 21:51 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5. veebr 2026, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

5. veebr 2026, 21:49 UTC

Tulu

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5. veebr 2026, 21:45 UTC

Tulu

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Võrdlus sarnastega

Hinnamuutus

Lexicon Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

214.84% tõus

12 kuu keskmine prognoos

Keskmine 4.03 USD 214.84%

Kõrge 6 USD

Madal 2.1 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Lexicon Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Lexicon Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.6863 / 0.72Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.